Lawrence Ho is a corporate associate in the New York office of Kirkland & Ellis LLP. His practice includes public and private mergers and acquisitions, capital markets transactions and debt finance transactions. Prior to joining Kirkland, Lawrence worked as an analyst in the corporate and investment banking group of a global investment bank in New York.
Experience
Representative Matters
Since joining Kirkland, Lawrence has been involved in the following matters, advising:
The Jordan Company-backed Sunny Sky Products in its acquisition of Bevolution Group, a provider of beverage solutions from Highlander Partners.
Apax Partners LLP in its ~$450 million investment in IBS Software.
Eli Lilly and Company (NYSE: LLY) in its acquisition of Versanis Bio, Inc. for up to $1.925 billion.
Waters Corporation (NYSE: WAT), a global leader in analytical instruments and software, in its acquisition of Wyatt Technology, a pioneer in innovative light scattering and field-flow fractionation instruments, software, accessories and services.
BC Partners in its acquisition of Madison Logic.
EQT and its portfolio company WorkWave, on WorkWave’s acquisition of TaskEasy.
Metromile in its acquisition by Lemonade through an all-stock merger transaction.
EQT and its portfolio company Recipharm, a global contract development and manufacturing organization (“CDMO”), on the acquisition of Vibalogics, a virotherapy CDMO, and Arranta Bio, a prominent advanced therapy CDMO.
Presidio, a BC Partners portfolio company, in its $150 million offering of senior unsecured notes.
KKR in connection with the financing for its investment in Beacon Pointe.
New Mountain Capital and its portfolio company TRC Companies, on a growth investment in TRC Companies from Warburg Pincus.
